Mitesco, Inc.

Mitesco, Inc. operates medical clinics under the The Good Clinic name in North East Minneapolis, the United States. It offers wellness coaching, behavioral health care, episodic care, dermatologic services, and supplements. The company was formerly known as True Nature Holding, Inc. and changed its name to Mitesco, Inc. in April 2020. Mitesco, Inc. is based in Saint Louis Park, Minnesota.

Mitesco, Inc. trades as MITI on OTC. The company is classified in Healthcare / Medical - Healthcare Information Services and reports in USD.

The current profile places the business in Medical - Healthcare Information Services. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $38,700 of revenue and $498,724 of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Mitesco, Inc. can be compared against peers such as Aion Therapeutic Inc., Caduceus Software Systems Corp., Strainsforpains, Inc., eWellness Healthcare Corporation, InterCare DX, Inc., Assure Holdings Corp..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $868,000, beta of 4.91, and return on equity of -2.1%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

MITI currently shows total debt of $1.61M and beta of 4.91. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

Recent filings to review: 10-Q (2026-05-20 00:00:00), NT 10-Q (2026-05-15 00:00:00), 8-K (2026-04-24 00:00:00), 3 (2026-04-20 00:00:00).

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.mitescoinc.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.